AVIR
AVIR
NASDAQ · Pharmaceuticals

Atea Pharmaceuticals Inc

$5.39
+0.06 (+1.13%)
As of Mar 25, 3:20 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 7 78%
Hold 2 22%
Sell 0 0%
Price Target
Analyst Price Target +754.4% upside
Low Target $31.54
Average Target $46.05
High Target $64.23
Current Price $5.39
Current
$5.39
Target
$46.05
$31.54 $46.05 avg $64.23
Scenario Analysis
Bear Case
$31.54
485.2%
Low target
Base Case
$46.05
+754.4%
Avg target
Bull Case
$64.23
+1,091.7%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$42.64
-87.4% from high
52-Week Low
$24.62
+-78.1% from low
Target vs 52W High
$46.05
+8.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%